Results 181 to 190 of about 24,482,117 (243)

Lead‐free halide perovskites for efficient light‐emitting devices

open access: yesFlexMat, EarlyView.
Overview of Lead‐free metal halide perovskites with different categories and optoelectronic application directions, including solid‐state lighting, light‐emitting diodes, piezoluminescence, flexible electronics, scintillators and CPL emitters. Abstract Lead halide perovskites exhibit promising optoelectronic properties for optoelectronic applications ...
Yueqi Shen   +9 more
wiley   +1 more source

Artificial intelligence and liquidation: Reality, destiny and fantasy

open access: yesInternational Insolvency Review, EarlyView.
Abstract Artificial intelligence (AI) is increasingly reshaping the administration of corporate liquidation. Beyond its established role in financial prediction and data analytics, AI is now assisting insolvency practitioners in identifying the onset of financial distress, managing creditor communications, tracing and valuing assets and enhancing ...
Kai Zhang, Jingchen Zhao
wiley   +1 more source

Availability of Stage Information From Cancer Registries Providing Data to the European Cancer Information System for Six Selected Cancers

open access: yesInternational Journal of Cancer, EarlyView.
The lack of a standardized cancer staging framework across European cancer registries has fragmented epidemiological data, making cross‐border comparisons of cancer indicators difficult. The present study assessed stage reporting for six cancer types from 86 population‐based cancer registries contributing to the European Cancer Information System ...
Cristina Bosetti   +96 more
wiley   +1 more source

Beyond seizure freedom: Reframing recovery in epilepsy

open access: yes
Epilepsia Open, EarlyView.
Giancarlo Di Gennaro, Andrea Tomasini
wiley   +1 more source

Global Real‐World Outcomes of Olaparib in Metastatic Castration‐Resistant Prostate Cancer Patients With Homologous Recombination Repair Alterations

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Evidence to guide the treatment for patients with metastatic castration‐resistant prostate cancer (mCRPC) and Homologous Recombination Repair (HRR) gene alterations outside of clinical trials remains limited. This was an observational, cohort study, including mCRPC patients with tumor harboring HRR alterations, progressed on a prior androgen ...
Lorena Incorvaia   +35 more
wiley   +1 more source

Home - About - Disclaimer - Privacy